Bioceptive, Inc. — Form D

Bioceptive, Inc. of NEW ORLEANS, LA, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-29. The offering totals $650K, of which $416K was reported sold. Industry: Biotechnology.

Offering

Filed: 2016-01-29
Form: D
Accession: 0001527900-16-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $650K
Amount sold: $416K
Remaining: $234K
Investors: 16
Date of first sale: 2016-01-18
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-256301

Issuer

Name: Bioceptive, Inc.
CIK: 0001527900
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2011
Address: NEW ORLEANS BIOINNOVATION CENTER, NEW ORLEANS, LA, 70112
Phone: (504) 598-5233

Officers, directors & promoters (12)

Name	Role	Location
Benjamin Cappiello	Director	New Orleans, LA
Orin Levy	Director	Boca Raton, FL
Joseph Kumar Lovett	Director	Baton Rouge, LA
Joan Neuscheler	Director	New Orleans, LA
Amit Kumar Rathi	Director	Bangalore, K7
Benjamin Cappiello	Executive Officer	New Orleans, LA
Shuchi Kumar Khurana	Executive Officer	New Orleans, LA
TOM BALDERSTON	Director	Atlanta, GA
Shuchi Khurana	Executive Officer	New Orleans, LA
Stewart Davis	Director	New Orleans, LA
Stewart Davis	Executive Officer	New Orleans, LA
John Hardman	Director	Atlanta, GA

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2013-12-30	D	$1.5M	$1.3M
2013-03-01	D/A	$1.1M	$1.1M
2012-10-24	D	$1.0M	—
2012-03-26	D	$200K	$40K
2012-03-26	D/A	$250K	$40K
2011-08-15	D	$135K	$135K

More